- Home
- XBIT vs CBUS Comparison
XBIT vs CBUS Comparison
Compare XBIT & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XBIT | CBUS |
|---|---|---|
| Founded | 2005 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Agricultural Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 73.2M | 69.9M |
| IPO Year | 2015 | 2017 |
Fundamental Metrics
Financial Performance| Metric | XBIT | CBUS |
|---|---|---|
| Price | $2.39 | $2.25 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | 46.3K | ★ 389.0K |
| Earning Date | 03-17-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,794,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $106.72 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.09 | $1.09 |
| 52 Week High | $3.62 | $3.40 |
Technical Indicators
Market Signals| Indicator | XBIT | CBUS |
|---|---|---|
| Relative Strength Index (RSI) | 38.90 | 64.40 |
| Support Level | $2.49 | $1.85 |
| Resistance Level | $2.66 | $1.90 |
| Average True Range (ATR) | 0.11 | 0.22 |
| MACD | -0.03 | 0.03 |
| Stochastic Oscillator | 18.91 | 85.87 |
Price Performance
Historical ComparisonAbout XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.